The device is under clinical trials at present. When you watch the video and listen to the patient who received one, it’s an incredible difference in how she feels and how much physical movement she has regained without being out of breath. BD
From the website:
The PARACHUTE TM procedure is performed in the cardiac catheterization lab or surgical suite, with the patient receiving local anesthesia. Under imaging guidance, the physician inserts the self-attaching PARACHUTE TM device through the femoral artery, and deploys it into the apex of the left ventricle. The PARACHUTE TM device partitions off the portion of the ventricle affected by the damaged myocardium, reducing the volume of the ventricle by approximately 20%, and reshapes the ventricle to a more natural conical shape. The reduced volume reduces wall stress and increases contractility and ejection fraction (a measure of the effectiveness of the ventricle).
The PARACHUTE TM device, implanted by an Interventional Cardiologist, has demonstrated in feasibility trials that patients experience a significant decrease in heart failure symptoms and an increase in exercise capacity and quality of life; with virtually no device related safety events. The feasibility trial also established that the device can be implanted with ease by interventional cardiologists under local anesthesia, with patients discharged in twenty-four hours.
(CBS) Congestive heart failure patients may soon be able to "parachute" their way to better lives. A new device, dubbed "the parachute," is meant to increase blood flow in those patients, and is doing well in clinical trials. The device, dubbed "the parachute," looks like an upside-down chute. A small incision is made in a leg artery, and it's snaked up to the damaged portion of the pumping chamber of the heart, isolating the inefficient portion of the weakened heart chamber and enabling blood to flow more effectively. Most patients are discharged from the hospital a day after the procedure.